Day: February 20, 2024

WATERTOWN, Mass., Feb. 20, 2024 (GLOBE NEWSWIRE) — Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced that the United States Food and Drug Administration (FDA) has granted Fast Track Designation to DISC-0974 for the treatment of patients with non-dialysis dependent chronic kidney disease (NDD-CKD) and anemia. “Receiving Fast Track designation highlights the unmet need for the millions of NDD-CKD patients with anemia, as well as the potential of DISC-0974 to address this need,” said John Quisel, J.D., Ph.D., President and Chief Executive Officer of Disc. “We believe DISC-0974 could be a transformative therapy for these patients and are excited to share...

ROSELAND, N.J., Feb. 20, 2024 (GLOBE NEWSWIRE) — Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announces it has commenced sales of its STA Single Tooth Anesthesia System® (STA) with Maine Dental Group, a premier group of 21 dental practices across the northeastern United States. Arjan Haverhals, Chief Executive Officer of Milestone Scientific, noted, “We are honored to add Maine Dental Group to our growing roster of dental practices, and believe this agreement is further validation of our new direct sales model, as well as our emphasis on Dental Service Organizations (DSOs) and large group practices, which we initiated last year. We are executing our new sales strategy, which allows us to leverage a lean sales organization,...

CarbonMeta and SIRC to launch cement-less concrete pilot project in March 2024 Riyadh, Saudi Arabia and Woodinville, WA, USA, Feb. 20, 2024 (GLOBE NEWSWIRE) — CarbonMeta Technologies Inc. (OTC PINK:COWI, “CarbonMeta”) announced today that it has won an 850,000 SAR (220,000 USD) sole source contract with Saudi Investment Recycling Company (SIRC) to develop and commercialize a carbon-negative concrete made from industrial, construction demolition waste and mining waste, and thereby provide sustainable, eco-friendly products for strategic construction projects in the Kingdom of Saudi Arabia (KSA). SIRC, a wholly owned subsidiary of the Saudi Public Investment Fund (PIF) of Saudi Arabia plans to attract over $13 billion in foreign direct investment and contribute over $30 billion to Saudi GDP by 2035, by investing in key technologies...

Q4 and FY 2023 Conference Call Set for Tuesday, February 27, 2024 at 4:30 p.m. ET Investor Day Scheduled for Thursday, March 14, 2024 at 8:00 a.m. ET in New York City FREMONT, Calif., Feb. 20, 2024 (GLOBE NEWSWIRE) —  SoundThinking, Inc. (Nasdaq: SSTI) (formerly ShotSpotter, Inc.), a leading public safety technology company, will hold a conference call on Tuesday, February 27, 2024 at 4:30 p.m. Eastern time to discuss its financial results for the fourth quarter and full year ended December 31, 2023. Financial results will be issued in a press release prior to the call. SoundThinking management will host an investor day for institutional investors and sell-side analysts on Thursday, March 14, 2024, at the Andaz 5th Avenue in New York, NY. Presentations are scheduled to begin at 8:00 a.m. Eastern time and end at approximately 12:00...

Cloud-native access gateway function (AGF) solution allows service providers offering both wireline and wireless services to eliminate redundant network core components and reduce capital and operating expenses. Casa’s AGF solution, now proven in private, and hybrid cloud environments, allows service providers to deploy and scale their services according to enterprise customer requirements. The work between Casa and AWS highlights the growing role of cloud-native network solutions in telecommunications.ANDOVER, Mass., Feb. 20, 2024 (GLOBE NEWSWIRE) — Casa Systems (Nasdaq: CASA), provider of cloud-native network solutions serving communications services providers worldwide, today announced a breakthrough in wireless wireline convergence (WWC): a successful deployment of Casa’s virtualized 5G Core control plane function on Amazon...

CAMBRIDGE, Mass., Feb. 20, 2024 (GLOBE NEWSWIRE) — Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the “Company”), a life science company committed to realizing the potential of mRNA cell engineering to provide patients with transformational new medicines, today announced the appointment of Peter Cicala, JD, to its Board of Directors. “Peter Cicala has deep experience in the biotechnology and pharmaceutical industry, from start-ups to big pharma, and from bench to commercialization,” said Sanjeev Luther, President and CEO of Eterna. “We are very pleased to have him join our Board to support value creation through the development of next-generation therapies using mRNA cell engineering.” Mr. Cicala’s professional expertise focuses on all aspects of pharmaceutical and biotechnology intellectual property and strategic management...

Amendment to existing exclusive license agreement with Orion Corporation expands Tenax’s territory rights from North America, to the entire world Expanded rights position Tenax to engage potential global strategic pharmaceutical partners Improved net sales royalty rate structure, now ranging from high single-digit to low-teen percentages. Lowered maximum cost of goods Modified milestone provisions, including additional payment for regulatory approval in Japan, reflect multi-billion dollar global PH-HFpEF opportunity Neurological indications excluded from Tenax’s right of first negotiation to commercialize new applications of levosimendan developed by OrionCHAPEL HILL, N.C., Feb. 20, 2024 (GLOBE NEWSWIRE) — Tenax Therapeutics, Inc. (Nasdaq: TENX), a Phase 3, development-stage pharmaceutical company focused on identifying, developing...

Merger Partner Notes Live Announces Acts Include OneRepublic, Dierks Bentley, Robert Plant/Alison Krauss, Beach Boys and Steve Miller Band CHARLOTTE, N.C., Feb. 20, 2024 (GLOBE NEWSWIRE) — Fresh Vine Wine Inc. (NYSE American: VINE) (“Fresh Vine”) today announced that it will hold a fireside chat with JW Roth, the CEO of Notes Live. The Company previously announced it had executed a definitive merger agreement (the “Merger Agreement”) to combine with Notes Live, Inc. (“Notes Live”), the Colorado-based live entertainment and hospitality company, that currently operates entertainment campuses in both the Colorado Springs, Colorado, and Atlanta, Georgia metropolitan areas. Notes Live recently announced that OneRepublic will headline its Sunset Amphitheater’s Grand Opening on Friday, August 9th. Booked exclusively in partnership...

SAN DIEGO, Feb. 20, 2024 (GLOBE NEWSWIRE) — KULR Technology Group, Inc. (NYSE American: KULR) (the “Company” or “KULR”), a global leader in sustainable energy management, today announced that the Company and YA II PN, LTD (“Yorkville”) have agreed that the remaining amount owed Yorkville shall not be due until December 31, 2024. Additionally, KULR filed a 14C Information Statement (link here) indicating additional corporate activity. KULR management believes these updated corporate governance provisions provide the ability to act in a timely manner when a meaningful strategic, financial, or commercial opportunity arises particularly in light of recent stock market price activity and valuations. KULR CEO Michael Mo recently sat down with host Stuart Smith to discuss the corporate activity and its potential...

MIAMI, Feb. 20, 2024 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for higher quality weight loss, oncology, and viral induced acute respiratory distress syndrome (ARDS), today announced the formation of a new Scientific Advisory Board to support the advancement of enobosarm, an oral novel selective androgen receptor modulator (SARM), to avoid muscle loss and augment fat loss when combined with a Glucagon-like peptide-1 receptor agonist (GLP-1 RA) drugs for potentially higher quality weight loss. The Scientific Advisory Board brings deep and complementary knowledge in metabolic diseases, obesity, weight management, muscle preservation and physical function in addition to significant experience in clinical research and...